欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1880/002
药品名称
Avaxim junior
活性成分
Hepatitis A virus, inactivated 80.0 ELISA unit/dos
剂型
Suspension for injection in pre-filled syringe
上市许可持有人
Sanofi Pasteur Europe
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
United Kingdom (Northern Ireland) (XI)
Spain (ES)
Italy (IT)
Greece (GR)
许可日期
2020/11/27
最近更新日期
2024/11/22
药物ATC编码
J07BC02 hepatitis A, inactivated, whole virus
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Biological: Vaccine
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
SE_H_1880_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1880_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase